Incyte: On a Growth Path With new Drugs Against Cancer and Autoimmune Diseases
Reading Time: 3 minutes
The number of diagnosed autoimmune diseases and cancers has significantly increased in recent years, primarily due to improved diagnostic capabilities. In Germany, the frequency of autoimmune diseases rose by 22% between 2012 and 2022, according to CompuGroup Medical. Furthermore, a study by Fortune Business Insights predicts that the global market for autoimmune diseases will grow by an average of 10.7% annually by 2030. For many of the approximately 80 known autoimmune diseases, there are currently no or only inadequate therapies available –...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
